Aging Population Will Drive Non-Invasive Diagnostic Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
03 Aug 25
Updated
03 Aug 25
AnalystHighTarget's Fair Value
US$101.00
64.8% undervalued intrinsic discount03 Aug
US$35.57
1Y
26.6%7D
-0.3%